MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 78 filers reported holding MERSANA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,937,182 | -81.8% | 2,312,742 | -52.9% | 0.00% | -100.0% |
Q2 2023 | $16,137,940 | -38.8% | 4,905,149 | -23.5% | 0.00% | 0.0% |
Q1 2023 | $26,354,232 | -61.6% | 6,412,222 | -45.3% | 0.00% | -50.0% |
Q4 2022 | $68,633,034 | +150.1% | 11,712,122 | +188.5% | 0.00% | 0.0% |
Q3 2022 | $27,439,000 | +266.5% | 4,059,020 | +150.5% | 0.00% | – |
Q2 2022 | $7,486,000 | +38.8% | 1,620,330 | +19.8% | 0.00% | – |
Q1 2022 | $5,395,000 | -79.4% | 1,352,150 | -68.0% | 0.00% | -100.0% |
Q4 2021 | $26,252,000 | -31.9% | 4,220,557 | +3.2% | 0.00% | -50.0% |
Q3 2021 | $38,571,000 | -12.5% | 4,090,196 | +26.0% | 0.00% | 0.0% |
Q2 2021 | $44,088,000 | -27.3% | 3,246,523 | -13.3% | 0.00% | -33.3% |
Q1 2021 | $60,610,000 | -27.8% | 3,746,000 | +18.7% | 0.00% | -40.0% |
Q4 2020 | $83,951,000 | +53.0% | 3,154,884 | +7.1% | 0.01% | +25.0% |
Q3 2020 | $54,872,000 | +49.8% | 2,946,913 | +88.2% | 0.00% | +33.3% |
Q2 2020 | $36,632,000 | +806.3% | 1,565,449 | +125.8% | 0.00% | – |
Q1 2020 | $4,042,000 | +13.6% | 693,327 | +11.7% | 0.00% | – |
Q4 2019 | $3,557,000 | +275.6% | 620,685 | +3.5% | 0.00% | – |
Q3 2019 | $947,000 | -56.5% | 599,660 | +11.5% | 0.00% | – |
Q2 2019 | $2,179,000 | +116.4% | 537,903 | +180.9% | 0.00% | – |
Q1 2019 | $1,007,000 | +40.4% | 191,490 | +8.9% | 0.00% | – |
Q4 2018 | $717,000 | -61.1% | 175,808 | -4.6% | 0.00% | – |
Q3 2018 | $1,843,000 | -40.8% | 184,197 | +5.8% | 0.00% | – |
Q2 2018 | $3,111,000 | +31.6% | 174,177 | +16.1% | 0.00% | – |
Q1 2018 | $2,364,000 | +225.6% | 149,982 | +240.2% | 0.00% | – |
Q4 2017 | $726,000 | +80.6% | 44,088 | +89.8% | 0.00% | – |
Q3 2017 | $402,000 | – | 23,231 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 1,191,271 | $6,980,848 | 6.79% |
Bain Capital Life Sciences Investors, LLC | 8,663,673 | $50,769 | 5.67% |
ACUTA CAPITAL PARTNERS, LLC | 950,000 | $5,567,000 | 3.43% |
Sarissa Capital Management LP | 3,997,010 | $23,422,479 | 2.79% |
Decheng Capital Management III (Cayman), LLC | 904,268 | $5,299,010 | 1.98% |
SILVERARC CAPITAL MANAGEMENT, LLC | 1,140,182 | $6,681,467 | 1.91% |
Orbimed Advisors | 9,011,437 | $52,807,021 | 1.01% |
Opaleye Management Inc. | 460,000 | $2,695,600 | 0.94% |
Artal Group S.A. | 2,200,000 | $12,892 | 0.72% |
DAFNA Capital Management LLC | 413,463 | $2,422,893 | 0.68% |